Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060748

See Remarks sold 358 shares at $81.14 ($29,048)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pinion John Richard See Remarks 2021-10-14 Sale −358 $81.14 $29,048 49,764 D: show line 1 in the form
Open-market sales · 358 sh · avg $81.14 · $29,048
Loading xslF345X03/doc4.xml…